4//SEC Filing
Howarth Alex G. 4
Accession 0001209191-20-054615
CIK 0001662524other
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 3:58 PM ET
Size
9.9 KB
Accession
0001209191-20-054615
Insider Transaction Report
Form 4
Howarth Alex G.
Chief Operating Officer
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2020-10-12$0.21/sh−300,000$63,000→ 0 totalExercise: $17.94Exp: 2029-12-01→ Common Stock (300,000 underlying) - Disposition from Tender
Common Stock
2020-10-12$18.15/sh−66,800$1,212,420→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2020-10-12$5.39/sh−34,200$184,338→ 0 totalExercise: $12.76Exp: 2030-03-18→ Common Stock (34,200 underlying)
Footnotes (2)
- [F1]This option, which provided that 25% of the shares would vest on December 2, 2020 and then in equal monthly installments over the next three years, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $63,000.00, representing the difference between the exercise price of the option and the acquisition price of $18.15.
- [F2]This option, which provided that 1/4th of the shares would vest one year after March 19, 2020 and 1/48th of the shares would vest monthly thereafter over the next three years, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $184,338.00, representing the difference between the exercise price of the option and the acquisition price of $18.15.
Documents
Issuer
AKCEA THERAPEUTICS, INC.
CIK 0001662524
Entity typeother
Related Parties
1- filerCIK 0001795798
Filing Metadata
- Form type
- 4
- Filed
- Oct 12, 8:00 PM ET
- Accepted
- Oct 13, 3:58 PM ET
- Size
- 9.9 KB